image
Energy - Oil & Gas Equipment & Services - NYSE - NL
$ 12.26
-2.85 %
$ 573 M
Market Cap
18.58
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one CLB stock under the worst case scenario is HIDDEN Compared to the current market price of 12.3 USD, Core Laboratories N.V. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one CLB stock under the base case scenario is HIDDEN Compared to the current market price of 12.3 USD, Core Laboratories N.V. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one CLB stock under the best case scenario is HIDDEN Compared to the current market price of 12.3 USD, Core Laboratories N.V. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CLB

image
$22.0$22.0$20.0$20.0$18.0$18.0$16.0$16.0$14.0$14.0$12.0$12.0$10.0$10.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
524 M REVENUE
2.76%
58.6 M OPERATING INCOME
7.17%
32.2 M NET INCOME
-13.16%
56.4 M OPERATING CASH FLOW
127.47%
-6.39 M INVESTING CASH FLOW
3.88%
-46 M FINANCING CASH FLOW
-149.16%
129 M REVENUE
-3.84%
14.2 M OPERATING INCOME
-28.42%
7.47 M NET INCOME
-36.41%
20.6 M OPERATING CASH FLOW
52.01%
-3.56 M INVESTING CASH FLOW
-571.52%
-19.4 M FINANCING CASH FLOW
-111.13%
Balance Sheet Core Laboratories N.V.
image
Current Assets 227 M
Cash & Short-Term Investments 19.2 M
Receivables 127 M
Other Current Assets 80.1 M
Non-Current Assets 364 M
Long-Term Investments 5.08 M
PP&E 154 M
Other Non-Current Assets 205 M
3.24 %21.57 %13.57 %26.01 %34.75 %Total Assets$590.4m
Current Liabilities 97.6 M
Accounts Payable 34.5 M
Short-Term Debt 10.7 M
Other Current Liabilities 52.3 M
Non-Current Liabilities 235 M
Long-Term Debt 169 M
Other Non-Current Liabilities 65.6 M
10.39 %3.21 %15.74 %50.94 %19.73 %Total Liabilities$332.7m
EFFICIENCY
Earnings Waterfall Core Laboratories N.V.
image
Revenue 524 M
Cost Of Revenue 435 M
Gross Profit 88.4 M
Operating Expenses 29.8 M
Operating Income 58.6 M
Other Expenses 26.4 M
Net Income 32.2 M
600m600m500m500m400m400m300m300m200m200m100m100m00524m(435m)88m(30m)59m(26m)32mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
16.87% GROSS MARGIN
16.87%
11.18% OPERATING MARGIN
11.18%
5.99% NET MARGIN
5.99%
33.25% ROE
33.25%
5.32% ROA
5.32%
8.10% ROIC
8.10%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Core Laboratories N.V.
image
200m200m180m180m160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 32.2 M
Depreciation & Amortization 15 M
Capital Expenditures -13 M
Stock-Based Compensation 3.76 M
Change in Working Capital 7.88 M
Others -5.03 M
Free Cash Flow 43.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Core Laboratories N.V.
image
Wall Street analysts predict an average 1-year price target for CLB of $23 , with forecasts ranging from a low of $17 to a high of $32 .
CLB Lowest Price Target Wall Street Target
17 USD 38.66%
CLB Average Price Target Wall Street Target
23 USD 87.60%
CLB Highest Price Target Wall Street Target
32 USD 161.01%
Price
Max Price Target
Min Price Target
Average Price Target
353530302525202015151010Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.06% DIVIDEND YIELD
0.01 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
2.50002.50002.00002.00001.50001.50001.00001.00000.50000.50000.00000.00000.550.550.550.550.550.250.550.550.550.550.550.550.550.550.550.550.552.200.552.200.552.200.552.200.552.200.280.040.040.040.040.012015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 13
6. Ownership
Insider Ownership Core Laboratories N.V.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch CLB's first-quarter revenues are likely to have declined from the year-ago period's level. However, cost reductions are expected to have provided modest relief. zacks.com - 1 week ago
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 weeks ago
Here's How to Play Core Labs Stock Ahead of Its Q1 Earnings Release CLB faces declining revenues, weak margins, geopolitical disruptions and inventory issues, with low dividend yield and overvaluation increasing investor caution. zacks.com - 2 weeks ago
CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. prnewswire.com - 1 month ago
Is Core Stock Worth Buying After a 27% Surge in 6 Months? CLB stock is supported by international expansion, proprietary tech and solid cash flow amid competitive pricing, volatile oil prices and geopolitical tensions. zacks.com - 1 month ago
Why Is Core Laboratories (CLB) Down 16% Since Last Earnings Report? Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? zacks.com - 2 months ago
CLB's Q4 Earnings Beat Estimates, Sales Lag, Expenses Increase Core Laboratories expects Reservoir Description revenues of $82-$85 million and Production Enhancement revenues of $39-$42 million for the first quarter of 2025. zacks.com - 3 months ago
Core Laboratories Inc. (CLB) Q4 2024 Earnings Conference Call Transcript Core Laboratories Inc. (NYSE:CLB ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Chris Hill - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel Josh Jayne - Daniel Energy Partners David Smith - Pickering Energy Partners Operator Good day, and welcome to the Core Laboratories' Fourth Quarter 2024 Earnings Call. All participants will be in listen-only mode. seekingalpha.com - 3 months ago
Core Laboratories (CLB) Misses Q4 Earnings and Revenue Estimates Core Laboratories (CLB) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.19 per share a year ago. zacks.com - 3 months ago
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEAR FOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12%  FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY  DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND FULL YEAR REVENUE OF $523.8 MILLION, UP 3% FULL YEAR OPERATING INCOME OF $58.6 MILLION; EX-ITEMS, $65.3 MILLION, UP 7% FULL YEAR GAAP EPS OF $0.66; EX-ITEMS, EPS OF $0.87, UP 9% FULL YEAR FREE CASH FLOW OF $43.4 MILLION, UP OVER 200% COMPARED TO 2023 HOUSTON , Jan. 29, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported fourth quarter 2024 revenue of $129,200,000. Core's operating income was $14,200,000, with diluted earnings per share ("EPS") of $0.15, all in accordance with U.S. generally accepted accounting principles ("GAAP"). prnewswire.com - 3 months ago
Core Laboratories to Post Q4 Earnings: Here's What to Expect CLB is expected to report higher revenues from the year-ago period's level. However, despite this revenue growth, the company is expected to face increased operating expenses. zacks.com - 3 months ago
Core Laboratories (CLB) Reports Next Week: Wall Street Expects Earnings Growth Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 3 months ago
8. Profile Summary

Core Laboratories N.V. CLB

image
COUNTRY NL
INDUSTRY Oil & Gas Equipment & Services
MARKET CAP $ 573 M
Dividend Yield 0.06%
Description Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Contact Van Heuven Goedhartlaan 7 B, Amstelveen, 1181 LE https://www.corelab.com
IPO Date Sept. 21, 1995
Employees 3500
Officers Mr. Sow Hang Teo Vice President, Treasurer & Chief Accounting Officer Ms. Gwendolyn Y. Gresham M.B.A. Senior Vice President of Corporate Development & Investor Relations J. Donald Dumas Jr. Senior Vice President of Production Enhancement & Business Development Mr. Lawrence V. Bruno Chairman of the Board, Chief Executive Officer, President & Chief Operating Officer Mr. Mark Damian Tattoli Senior Vice President, Secretary & General Counsel Leslie D. Linklater Vice President People, Organization, & Culture Mr. Jacobus Schouten Managing Director Mr. Christopher Scott Hill Senior Vice President & Chief Financial Officer Billy Anthony President of Owen Oil Tools